Advertisement
Screener

CERO THERAPEUTICS HOLDINGS, INC. (CERO) Interest Income (Expense), Nonoperating, Net

2.8 / 5 stars · 68/120 Roast Me

CERO THERAPEUTICS HOLDINGS, INC. Interest Income (Expense), Nonoperating, Net

CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Interest Income (Expense), Nonoperating, Net of $5.94 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.

Financial Statements › Income Statement › Other Income

us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2025-11-19

  • CERO THERAPEUTICS HOLDINGS, INC. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $5.94K, a 34.36% increase year-over-year.
  • CERO THERAPEUTICS HOLDINGS, INC. interest income (expense), nonoperating, net for the quarter ending 2025-06-30 was $13.78K.
  • CERO THERAPEUTICS HOLDINGS, INC. interest income (expense), nonoperating, net for the quarter ending 2025-03-31 was $850.00.
  • CERO THERAPEUTICS HOLDINGS, INC. interest income (expense), nonoperating, net for the quarter ending 2024-09-30 was $4.42K.
Period endInterest Income (Expense), Nonoperating, Net 1 monthInterest Income (Expense), Nonoperating, Net 2 monthInterest Income (Expense), Nonoperating, Net 3 monthInterest Income (Expense), Nonoperating, Net 5 monthInterest Income (Expense), Nonoperating, Net 6 monthInterest Income (Expense), Nonoperating, Net 8 monthInterest Income (Expense), Nonoperating, Net 9 month
2025-09-30$5.94K
10-Q · filed 2025-11-19
$19.71K
derived: sum of 2 quarters · filed 2025-11-19
$20.56K
10-Q · filed 2025-11-19
2025-06-30$13.78K
10-Q · filed 2025-08-22
$14.63K
10-Q · filed 2025-08-22
2025-03-31$850.00
10-Q · filed 2025-05-15
2024-09-30$4.42K
10-Q · filed 2025-11-19
-$12.56K
derived: sum of 2 quarters · filed 2025-11-19
-$26.99K
10-Q · filed 2025-11-19
2024-06-30-$16.98K
10-Q · filed 2025-08-22
-$31.41K
10-Q · filed 2025-08-22
2024-03-31-$14.43K
10-Q · filed 2025-05-15
2024-02-13$4.80K
10-Q · filed 2025-11-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
AIM ImmunoTech Inc. (AIM)United States$0.006B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
IN8BIO, INC. (INAB)United States$0.012B-0.76
CURIS INC (CRIS)United States$0.002B-0.05